mojeNovosti.com
Mixed message on antidepressant for hot flashes[2012-04-24 07:00:00]
NEW YORK (Reuters Health) - New findings suggest that the antidepressant Lexapro might make hot flashes a little less of a nuisance...
Medicare trustee report hangs on uncertain assumptions[2012-04-24 07:00:00]
WASHINGTON (Reuters) - Medicare, the U.S. healthcare program for the elderly, should be able to stave off insolvency for the next 12...
FDA staff doubt Cameron device better than rivals[2012-04-24 07:00:00]
WASHINGTON (Reuters) - U.S. medical device reviewers said the first defibrillator designed to be implanted directly under the skin may cause more...
[2012-04-24 07:00:00]
NEW YORK (Reuters Health) - In a new study of more than 1,200 Asian women, those who took aspirin at least a...
[2012-04-24 07:00:00]
NEW YORK (Reuters Health) - Colonoscopy has become an increasingly popular method of screening for colon cancer while the rate of at-home...
[2012-04-24 07:00:00]
NEW YORK (Reuters) - Swiss food group Nestle SA may sell about 10 to 15 percent of the $11.9 billion baby food...
[2012-04-24 07:00:00]
NEW YORK (Reuters Health) - Doctors' belief that certain antidepressants can help to treat repetitive behaviors in kids with autism may be...
[2012-04-23 07:37:00]
ZURICH (Reuters) - Swiss food group Nestle said on Monday it would buy U.S. drugmaker Pfizer's infant nutrition business for $11.85 billion,...
Anti-cholesterol statins don't reduce melanoma risk: study[2012-04-23 07:00:00]
(Reuters) - Despite earlier indications that people taking cholesterol-lowering statins might have a reduced risk of developing melanoma, a study of thousands...
[2012-04-22 07:00:00]
ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling...
University of Colorado clamps down on "pot fest" but many light up[2012-04-21 07:00:00]
BOULDER, Colo. (Reuters) - The University of Colorado sought on Friday to clamp down on a huge annual marijuana fest, but after...
[2012-04-21 07:00:00]
LONDON (Reuters) - European and U.S. regulators have backed the continued use of Novartis AG's multiple sclerosis pill Gilenya, one of the...
Fish oil supplements don't help MS patients: study[2012-04-21 07:00:00]
NEW YORK (Reuters Health) - Many people with multiple sclerosis take fish oil pills with the hope of keeping neurological symptoms from...
Statins don't reduce melanoma risk: study[2012-04-21 07:00:00]
NEW YORK (Reuters Health) - Despite earlier indications that people taking statins might have a reduced risk of developing melanoma, a large...
Measles cases reached 15-year high in 2011: CDC[2012-04-21 07:00:00]
ATLANTA (Reuters) - Measles cases in the United States hit a 15-year high in 2011, with 90 percent of the cases traced...
[2012-04-21 07:00:00]
KATHMANDU (Reuters) - A team of U.S. scientists departed on Friday to conduct research on Mount Everest climbers in an effort to...
FDA says nanotech may need extra safety tests[2012-04-21 07:00:00]
WASHINGTON (Reuters) - U.S. health regulators said consumer products that use nanotechnology may have unknown effects on the human body, and advised...
Big regional differences in glaucoma diagnosis found[2012-04-21 07:00:00]
NEW YORK (Reuters Health) - A new analysis of Medicare records finds dramatic differences across the U.S. in rates of new glaucoma...
[2012-04-21 07:00:00]
NEW YORK (Reuters Health) - Many people treated for cancer are worn out for a time, but new findings suggest that long-lasting...
Study finds high rates of off-label prescribing[2012-04-20 07:00:00]
NEW YORK (Reuters Health) - More than 10 percent of prescriptions in one Canadian province were for drugs not approved to treat...
Copyright 2013 mojeNovosti.com
web developer: BTGcms
